Literature DB >> 22452682

Vogt-Koyanagi-Harada disease presenting as acute angle closure glaucoma at onset.

Peizeng Yang1, Xiaoli Liu, Hongyan Zhou, Wenjuan Guo, Chunjiang Zhou, Aize Kijlstra.   

Abstract

BACKGROUND: To investigate the clinical features of Vogt-Koyanagi-Harada (VKH) disease presenting as acute angle closure glaucoma at onset.
DESIGN: Retrospective non-comparative case series. PARTICIPANTS: Four hundred and eighty-six VKH patients seen from February 2001 to March 2010.
METHODS: The history and clinical findings of all patients were reviewed. Auxiliary examinations, including ultrasound biomicroscopy, fundus fluorescein angiography and optical coherence tomography, were performed in certain cases. Corticosteroids with or without cyclosporine A were used to treat these patients. MAIN OUTCOME MEASURE: Patients' demographics, clinical presentation and auxiliary examination findings.
RESULTS: Eight out of 486 VKH patients were misdiagnosed as acute angle closure glaucoma. The mean age of these eight patients was 55.6 years. Six patients were female. The mean intraocular pressure (IOP) at disease onset was 32.9 mmHg. All of these patients had a shallow anterior chamber and a narrow or closed angle at their first visit. The complaints of these patients were mostly headache and sudden decreased vision in both eyes. Alterations shown on ultrasound biomicroscopy included detachment of the ciliary body and peripheral choroid. The increased IOP did not respond to anti-glaucoma therapy, but resolved following treatment with corticosteroids. The eye of one patient was enucleated after failed trabeculectomies prior to referral to our uveitis centre.
CONCLUSION: VKH disease presenting with a bilateral increased IOP mostly occurs in older women. The strikingly decreased visual acuity associated with mild to moderate increased IOP is a clue to the diagnosis. The increased IOP responded well to corticosteroids but not to anti-glaucoma treatment.
© 2011 The Authors. Clinical and Experimental Ophthalmology © 2011 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22452682     DOI: 10.1111/j.1442-9071.2011.02523.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  6 in total

1.  High prevalence of angle-closure glaucoma in Vogt-Koyanagi-Harada disease.

Authors:  Carlos Alvarez-Guzman; Jorge E Valdez-Garcia; Raul E Ruiz-Lozano; Alejandro Rodriguez-Garcia; Carlos F Navas-Villar; Curt Hartleben-Matkin; Miguel Pedroza-Seres
Journal:  Int Ophthalmol       Date:  2022-07-05       Impact factor: 2.031

Review 2.  Vogt-Koyanagi-Harada syndrome - current perspectives.

Authors:  Abeir Baltmr; Sue Lightman; Oren Tomkins-Netzer
Journal:  Clin Ophthalmol       Date:  2016-11-24

3.  Angiographic features of drug-induced bilateral angle closure and transient myopia with Ciliochoroidal effusion.

Authors:  Yong Koo Kang; Byeong Jae Son; Dong Ho Park; Jae Pil Shin
Journal:  BMC Ophthalmol       Date:  2019-11-04       Impact factor: 2.209

4.  Vogt-Koyanagi-Harada disease associated with anterior ischemic optic neuropathy in a young woman presenting as acute angle closure glaucoma.

Authors:  Sagarika Patyal; Ritesh Narula; Mithun Thulasidas
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

5.  Case Report: Vogt-Koyanagi-Harada Syndrome Mimicking Acute Angle-Closure Glaucoma in a Patient Infected With Human Immunodeficiency Virus.

Authors:  Xue Bai; Rui Hua
Journal:  Front Med (Lausanne)       Date:  2022-01-12

6.  Adalimumab in Vogt-Koyanagi-Harada Disease Refractory to Conventional Therapy.

Authors:  Shizhao Yang; Tianyu Tao; Zhaohao Huang; Xiuxing Liu; He Li; Lihui Xie; Feng Wen; Wei Chi; Wenru Su
Journal:  Front Med (Lausanne)       Date:  2022-01-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.